Regeneron Extends Its Run as S&P 500’s Top Stock After Covid-19 Drug Update

(Bloomberg) -- Regeneron Pharmaceuticals Inc. is building on its position as the best performing stock in the S&P 500 this year as investors swoon over cancer drug data, booming sales, and an updat...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.